These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia. McEvoy C; Bowling S; Williamson K; McGaw P; Durand M Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874 [TBL] [Abstract][Full Text] [Related]
23. Hypernatraemia in preterm infants born at less than 27 weeks gestation. Gawlowski Z; Aladangady N; Coen PG J Paediatr Child Health; 2006 Dec; 42(12):771-4. PubMed ID: 17096711 [TBL] [Abstract][Full Text] [Related]
24. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants. Romagnoli C; Zecca E; Papacci P; De Carolis MP; Giannini R; Gallini F; Tortorolo G Clin Pharmacol Ther; 1997 Aug; 62(2):181-6. PubMed ID: 9284854 [TBL] [Abstract][Full Text] [Related]
25. Circulating prostaglandin E2 concentrations and incidence of patent ductus arteriosus in preterm infants with respiratory distress syndrome. Clyman RI; Brett C; Mauray F Pediatrics; 1980 Nov; 66(5):725-9. PubMed ID: 7432878 [TBL] [Abstract][Full Text] [Related]
26. A prospective observational pilot study of synchronized nasal intermittent positive pressure ventilation (SNIPPV) as a primary mode of ventilation in infants > or = 28 weeks with respiratory distress syndrome (RDS). Santin R; Brodsky N; Bhandari V J Perinatol; 2004 Aug; 24(8):487-93. PubMed ID: 15141265 [TBL] [Abstract][Full Text] [Related]
27. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766 [TBL] [Abstract][Full Text] [Related]
28. Factors associated with growth of extremely premature infants during initial hospitalization. Berry MA; Abrahamowicz M; Usher RH Pediatrics; 1997 Oct; 100(4):640-6. PubMed ID: 9310518 [TBL] [Abstract][Full Text] [Related]
29. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier. Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616 [TBL] [Abstract][Full Text] [Related]
30. Association between neonatal care practices and efficacy of exogenous human surfactant: results of a bicenter randomized trial. Hallman M; Merritt TA; Bry K; Berry C Pediatrics; 1993 Mar; 91(3):552-60. PubMed ID: 8441558 [TBL] [Abstract][Full Text] [Related]
31. [Prematurity risk according to prematurity risk score and postpartal morbidity of the newborn infants (author's transl)]. Coradello H; Lubec G; Simbruner G Z Geburtshilfe Perinatol; 1981 Feb; 185(1):41-6. PubMed ID: 7195117 [TBL] [Abstract][Full Text] [Related]
32. Nutrient intakes and growth of very low birth weight infants. Carlson SJ; Ziegler EE J Perinatol; 1998; 18(4):252-8. PubMed ID: 9730193 [TBL] [Abstract][Full Text] [Related]
33. High-frequency jet ventilation in the early management of respiratory distress syndrome is associated with a greater risk for adverse outcomes. Wiswell TE; Graziani LJ; Kornhauser MS; Cullen J; Merton DA; McKee L; Spitzer AR Pediatrics; 1996 Dec; 98(6 Pt 1):1035-43. PubMed ID: 8951251 [TBL] [Abstract][Full Text] [Related]
34. Controversies in fluid and electrolyte therapy for the premature infant. Costarino AT; Baumgart S Clin Perinatol; 1988 Dec; 15(4):863-78. PubMed ID: 3061703 [TBL] [Abstract][Full Text] [Related]
35. [Daily creatinine excretion in urine in the first 3 days of life and its relation to maturity, body weight and infusion quantity]. von Stockhausen HB; Müller-Wiefel D; Struve M Monatsschr Kinderheilkd (1902); 1976 May; 124(5):456-8. PubMed ID: 934151 [No Abstract] [Full Text] [Related]
36. [Blood creatinine and urinary clearance of endogenous creatinine during the first month of life in the healthy premature neonate]. Colonna F; de Vonderweid U; Tecilazich D; Stormi M Minerva Pediatr; 1983 Jun; 35(12):639-44. PubMed ID: 6633468 [No Abstract] [Full Text] [Related]
37. Renal function and fluid therapy in high risk infants. Oh W Biol Neonate; 1988; 53(4):230-6. PubMed ID: 3046669 [TBL] [Abstract][Full Text] [Related]
38. Respiratory distress in the newborn. Kishan J; Rehman F Indian Pediatr; 1982 Jul; 19(7):619-26. PubMed ID: 7174092 [No Abstract] [Full Text] [Related]
39. Plasma amino acid profiles during the first three days of life in infants with respiratory distress syndrome: effect of parenteral amino acid supplementation. Rivera A; Bell EF; Stegink LD; Ziegler EE J Pediatr; 1989 Sep; 115(3):465-8. PubMed ID: 2769509 [No Abstract] [Full Text] [Related]
40. [Variants of the adverse reactions to infusion therapy in premature infants and their diagnosis]. Katricheva-Loginova LV; Kaganova TI Pediatriia; 1985 Sep; (9):29-33. PubMed ID: 4080477 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]